Furthermore, it has been reported that CH is highly prevalent in patients with solid tumors, and DNA damage repair genes (eg, TP53, PPM1D) that cause CH are more frequently mutated [14,15]. This evidence concerns the gene PPM1D and cyclic hematopoiesis.